Tdspharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 25, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	56,019	73,217	-	-	-	-
Enterprise Value	32,269	48,283	-	-	-	-
Last Close Price	10130.00	13240.00	-	-	-	-
PE Ratio	16.33	19.69	-	-	-	-
PS Ratio	2.28	2.66	-	-	-	-
PB Ratio	1.36	1.90	-	-	-	-
P/TBV Ratio	1.36	1.91	-	-	-	-
P/FCF Ratio	62.60	22.79	-	-	-	-
P/OCF Ratio	26.65	18.64	-	-	-	-
EV/Sales Ratio	1.31	1.76	-	-	-	-
EV/EBITDA Ratio	10.18	10.98	-	-	-	-
EV/EBIT Ratio	13.17	12.95	-	-	-	-
EV/FCF Ratio	36.06	15.03	-	-	-	-
Debt / Equity Ratio	0.16	0.18	0.31	0.38	0.44	0.43
Debt / EBITDA Ratio	2.04	1.57	1.18	1.38	2.01	2.49
Debt / FCF Ratio	7.21	2.15	2.32	3.00	2.05	3.56
Net Debt / Equity Ratio	-0.58	-0.62	-0.35	-0.16	-0.06	-0.02
Net Debt / EBITDA Ratio	-7.49	-5.41	-1.32	-0.59	-0.28	-0.10
Net Debt / FCF Ratio	-26.54	-7.40	-2.59	-1.29	-0.28	-0.14
Asset Turnover	0.48	0.66	0.93	0.89	0.74	0.72
Inventory Turnover	5.82	7.02	9.51	9.49	8.63	8.30
Quick Ratio	3.54	3.46	2.18	1.59	1.16	1.14
Current Ratio	3.82	3.77	2.43	1.83	1.37	1.34
Return on Equity (ROE)	8.30%	12.10%	22.73%	20.06%	12.70%	9.59%
Return on Assets (ROA)	3.01%	5.61%	9.73%	8.23%	5.40%	4.06%
Return on Invested Capital (ROIC)	12.53%	22.18%	28.30%	22.29%	12.65%	8.48%
Return on Capital Employed (ROCE)	5.90%	9.70%	21.00%	18.30%	13.30%	9.30%
Earnings Yield	5.86%	5.08%	-	-	-	-
FCF Yield	1.60%	4.39%	-	-	-	-
Buyback Yield / Dilution	-20.99%	-8.74%	0.07%	-4511.34%	7.60%	0.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.